nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonidine—SLC22A1—hematologic cancer	0.195	0.775	CbGaD
Clonidine—ABCB1—hematologic cancer	0.0567	0.225	CbGaD
Clonidine—SLC22A3—Melphalan—hematologic cancer	0.0462	0.0965	CbGbCtD
Clonidine—SLC22A3—Irinotecan—hematologic cancer	0.0156	0.0327	CbGbCtD
Clonidine—SLC22A1—Cytarabine—hematologic cancer	0.0148	0.031	CbGbCtD
Clonidine—CYP1A2—Anagrelide—hematologic cancer	0.0145	0.0303	CbGbCtD
Clonidine—CYP1A1—Methoxsalen—hematologic cancer	0.0145	0.0303	CbGbCtD
Clonidine—SLC22A1—Cladribine—hematologic cancer	0.014	0.0293	CbGbCtD
Clonidine—CYP1A1—Bortezomib—hematologic cancer	0.0138	0.0288	CbGbCtD
Clonidine—SLC22A3—Vincristine—hematologic cancer	0.0137	0.0286	CbGbCtD
Clonidine—CYP1A1—Daunorubicin—hematologic cancer	0.0132	0.0275	CbGbCtD
Clonidine—SLC22A1—Imatinib—hematologic cancer	0.0129	0.0269	CbGbCtD
Clonidine—CYP1A1—Thalidomide—hematologic cancer	0.012	0.0251	CbGbCtD
Clonidine—CYP1A1—Dacarbazine—hematologic cancer	0.0103	0.0216	CbGbCtD
Clonidine—ABCB1—Lenalidomide—hematologic cancer	0.00878	0.0184	CbGbCtD
Clonidine—CYP1A1—Dasatinib—hematologic cancer	0.00811	0.0169	CbGbCtD
Clonidine—CYP3A5—Daunorubicin—hematologic cancer	0.00791	0.0165	CbGbCtD
Clonidine—CYP2D6—Lomustine—hematologic cancer	0.00769	0.0161	CbGbCtD
Clonidine—CYP1A2—Carmustine—hematologic cancer	0.00761	0.0159	CbGbCtD
Clonidine—CYP3A5—Thalidomide—hematologic cancer	0.0072	0.0151	CbGbCtD
Clonidine—CYP3A5—Teniposide—hematologic cancer	0.00687	0.0144	CbGbCtD
Clonidine—CYP2D6—Idarubicin—hematologic cancer	0.00686	0.0143	CbGbCtD
Clonidine—CYP1A2—Methoxsalen—hematologic cancer	0.00647	0.0135	CbGbCtD
Clonidine—CYP3A5—Ifosfamide—hematologic cancer	0.00634	0.0133	CbGbCtD
Clonidine—CYP1A2—Bortezomib—hematologic cancer	0.00616	0.0129	CbGbCtD
Clonidine—CYP3A5—Imatinib—hematologic cancer	0.00606	0.0127	CbGbCtD
Clonidine—CYP1A2—Daunorubicin—hematologic cancer	0.00589	0.0123	CbGbCtD
Clonidine—CYP2D6—Hydroxyurea—hematologic cancer	0.00583	0.0122	CbGbCtD
Clonidine—CYP1A2—Alitretinoin—hematologic cancer	0.00577	0.0121	CbGbCtD
Clonidine—CYP1A2—Thalidomide—hematologic cancer	0.00536	0.0112	CbGbCtD
Clonidine—CYP3A4—Bexarotene—hematologic cancer	0.00526	0.011	CbGbCtD
Clonidine—ABCB1—Daunorubicin—hematologic cancer	0.00515	0.0108	CbGbCtD
Clonidine—CYP2D6—Bortezomib—hematologic cancer	0.00507	0.0106	CbGbCtD
Clonidine—ABCB1—Alitretinoin—hematologic cancer	0.00504	0.0105	CbGbCtD
Clonidine—CYP3A4—Lomustine—hematologic cancer	0.00489	0.0102	CbGbCtD
Clonidine—CYP3A4—Busulfan—hematologic cancer	0.00489	0.0102	CbGbCtD
Clonidine—CYP3A5—Dasatinib—hematologic cancer	0.00487	0.0102	CbGbCtD
Clonidine—CYP1A2—Dacarbazine—hematologic cancer	0.00461	0.00964	CbGbCtD
Clonidine—CYP1A2—Imatinib—hematologic cancer	0.00451	0.00943	CbGbCtD
Clonidine—CYP3A4—Thiotepa—hematologic cancer	0.00436	0.00911	CbGbCtD
Clonidine—CYP1A1—Dexamethasone—hematologic cancer	0.00415	0.00868	CbGbCtD
Clonidine—ABCB1—Imatinib—hematologic cancer	0.00394	0.00824	CbGbCtD
Clonidine—CYP3A5—Irinotecan—hematologic cancer	0.00378	0.00791	CbGbCtD
Clonidine—CYP2D6—Imatinib—hematologic cancer	0.00372	0.00777	CbGbCtD
Clonidine—CYP1A2—Dasatinib—hematologic cancer	0.00362	0.00757	CbGbCtD
Clonidine—ABCB1—Nilotinib—hematologic cancer	0.00358	0.00749	CbGbCtD
Clonidine—ABCB1—Vinorelbine—hematologic cancer	0.00355	0.00743	CbGbCtD
Clonidine—CYP3A4—Methoxsalen—hematologic cancer	0.00339	0.00709	CbGbCtD
Clonidine—CYP2D6—Nilotinib—hematologic cancer	0.00338	0.00706	CbGbCtD
Clonidine—CYP2D6—Vinorelbine—hematologic cancer	0.00335	0.007	CbGbCtD
Clonidine—CYP3A5—Vincristine—hematologic cancer	0.00331	0.00691	CbGbCtD
Clonidine—CYP3A4—Bortezomib—hematologic cancer	0.00322	0.00674	CbGbCtD
Clonidine—ABCB1—Dasatinib—hematologic cancer	0.00317	0.00662	CbGbCtD
Clonidine—ABCB1—Mitoxantrone—hematologic cancer	0.00313	0.00654	CbGbCtD
Clonidine—CYP3A4—Daunorubicin—hematologic cancer	0.00308	0.00645	CbGbCtD
Clonidine—CYP3A5—Etoposide—hematologic cancer	0.00303	0.00634	CbGbCtD
Clonidine—ABCB1—Betamethasone—hematologic cancer	0.00279	0.00583	CbGbCtD
Clonidine—ABCB1—Gemcitabine—hematologic cancer	0.00276	0.00578	CbGbCtD
Clonidine—ABCB1—Prednisolone—hematologic cancer	0.00275	0.00575	CbGbCtD
Clonidine—CYP3A4—Cytarabine—hematologic cancer	0.00272	0.00569	CbGbCtD
Clonidine—CYP3A4—Teniposide—hematologic cancer	0.00268	0.0056	CbGbCtD
Clonidine—ABCB1—Prednisone—hematologic cancer	0.0026	0.00543	CbGbCtD
Clonidine—CYP3A5—Dexamethasone—hematologic cancer	0.00249	0.00521	CbGbCtD
Clonidine—CYP3A4—Ifosfamide—hematologic cancer	0.00247	0.00517	CbGbCtD
Clonidine—ABCB1—Irinotecan—hematologic cancer	0.00246	0.00515	CbGbCtD
Clonidine—CYP3A4—Imatinib—hematologic cancer	0.00236	0.00494	CbGbCtD
Clonidine—CYP1A2—Etoposide—hematologic cancer	0.00226	0.00472	CbGbCtD
Clonidine—CYP3A4—Ruxolitinib—hematologic cancer	0.00222	0.00465	CbGbCtD
Clonidine—ABCB1—Vinblastine—hematologic cancer	0.00219	0.00458	CbGbCtD
Clonidine—ABCB1—Vincristine—hematologic cancer	0.00215	0.0045	CbGbCtD
Clonidine—CYP3A4—Nilotinib—hematologic cancer	0.00215	0.00449	CbGbCtD
Clonidine—CYP3A4—Vinorelbine—hematologic cancer	0.00213	0.00445	CbGbCtD
Clonidine—CYP2D6—Vinblastine—hematologic cancer	0.00206	0.00431	CbGbCtD
Clonidine—ABCB1—Cisplatin—hematologic cancer	0.00201	0.0042	CbGbCtD
Clonidine—ABCB1—Etoposide—hematologic cancer	0.00197	0.00412	CbGbCtD
Clonidine—CYP3A4—Triamcinolone—hematologic cancer	0.00195	0.00407	CbGbCtD
Clonidine—CYP3A4—Dasatinib—hematologic cancer	0.0019	0.00397	CbGbCtD
Clonidine—CYP3A4—Mitoxantrone—hematologic cancer	0.00187	0.00392	CbGbCtD
Clonidine—CYP3A4—Betamethasone—hematologic cancer	0.00167	0.00349	CbGbCtD
Clonidine—CYP3A4—Prednisolone—hematologic cancer	0.00165	0.00345	CbGbCtD
Clonidine—ABCB1—Dexamethasone—hematologic cancer	0.00162	0.00339	CbGbCtD
Clonidine—CYP3A4—Prednisone—hematologic cancer	0.00156	0.00325	CbGbCtD
Clonidine—CYP2D6—Dexamethasone—hematologic cancer	0.00153	0.00319	CbGbCtD
Clonidine—CYP3A4—Irinotecan—hematologic cancer	0.00148	0.00308	CbGbCtD
Clonidine—ABCB1—Doxorubicin—hematologic cancer	0.00135	0.00281	CbGbCtD
Clonidine—CYP3A4—Vinblastine—hematologic cancer	0.00131	0.00274	CbGbCtD
Clonidine—ABCB1—Methotrexate—hematologic cancer	0.0013	0.00272	CbGbCtD
Clonidine—CYP3A4—Vincristine—hematologic cancer	0.00129	0.0027	CbGbCtD
Clonidine—CYP2D6—Doxorubicin—hematologic cancer	0.00127	0.00265	CbGbCtD
Clonidine—CYP3A4—Etoposide—hematologic cancer	0.00118	0.00247	CbGbCtD
Clonidine—CYP3A4—Dexamethasone—hematologic cancer	0.000972	0.00203	CbGbCtD
Clonidine—CYP3A4—Doxorubicin—hematologic cancer	0.000806	0.00169	CbGbCtD
Clonidine—NISCH—blood—hematologic cancer	0.00075	0.0392	CbGeAlD
Clonidine—NISCH—bone marrow—hematologic cancer	0.000726	0.0379	CbGeAlD
Clonidine—SLC22A3—hematopoietic system—hematologic cancer	0.000681	0.0356	CbGeAlD
Clonidine—NISCH—lung—hematologic cancer	0.000657	0.0343	CbGeAlD
Clonidine—NISCH—testis—hematologic cancer	0.00062	0.0324	CbGeAlD
Clonidine—NISCH—Podofilox—Teniposide—hematologic cancer	0.000613	0.226	CbGdCrCtD
Clonidine—ADRA1A—hematopoietic system—hematologic cancer	0.000543	0.0283	CbGeAlD
Clonidine—SLC22A3—gonad—hematologic cancer	0.000518	0.027	CbGeAlD
Clonidine—SLC22A4—blood—hematologic cancer	0.000496	0.0259	CbGeAlD
Clonidine—SLC22A4—bone marrow—hematologic cancer	0.00048	0.0251	CbGeAlD
Clonidine—SLC22A1—blood—hematologic cancer	0.000472	0.0247	CbGeAlD
Clonidine—NISCH—Menadione—Thalidomide—hematologic cancer	0.000465	0.171	CbGdCrCtD
Clonidine—NISCH—lymph node—hematologic cancer	0.00045	0.0235	CbGeAlD
Clonidine—CYP1A2—hematopoietic system—hematologic cancer	0.000449	0.0234	CbGeAlD
Clonidine—SLC6A2—gonad—hematologic cancer	0.000444	0.0232	CbGeAlD
Clonidine—CYP1A1—hematopoietic system—hematologic cancer	0.000443	0.0231	CbGeAlD
Clonidine—SLC22A4—lung—hematologic cancer	0.000435	0.0227	CbGeAlD
Clonidine—CYP3A5—hematopoietic system—hematologic cancer	0.000433	0.0226	CbGeAlD
Clonidine—ADRA2A—hematopoietic system—hematologic cancer	0.000413	0.0215	CbGeAlD
Clonidine—Diclofenac—ALOX5—hematologic cancer	0.000397	0.435	CrCbGaD
Clonidine—SLC22A3—lung—hematologic cancer	0.000396	0.0207	CbGeAlD
Clonidine—NISCH—Vincristine—Vinorelbine—hematologic cancer	0.00039	0.144	CbGdCrCtD
Clonidine—SLC22A3—testis—hematologic cancer	0.000373	0.0195	CbGeAlD
Clonidine—NISCH—Podofilox—Etoposide—hematologic cancer	0.000365	0.135	CbGdCrCtD
Clonidine—ADRA1A—blood—hematologic cancer	0.000359	0.0188	CbGeAlD
Clonidine—Diclofenac—UGT1A1—hematologic cancer	0.000348	0.382	CrCbGaD
Clonidine—ADRA2C—blood—hematologic cancer	0.000343	0.0179	CbGeAlD
Clonidine—SLC6A2—lung—hematologic cancer	0.000339	0.0177	CbGeAlD
Clonidine—SLC22A5—blood—hematologic cancer	0.000328	0.0171	CbGeAlD
Clonidine—CYP3A4—hematopoietic system—hematologic cancer	0.000325	0.017	CbGeAlD
Clonidine—SLC6A2—testis—hematologic cancer	0.00032	0.0167	CbGeAlD
Clonidine—CYP2D6—hematopoietic system—hematologic cancer	0.00032	0.0167	CbGeAlD
Clonidine—NISCH—Vinblastine—Vinorelbine—hematologic cancer	0.000314	0.116	CbGdCrCtD
Clonidine—ADRA2A—gonad—hematologic cancer	0.000314	0.0164	CbGeAlD
Clonidine—NISCH—Vincristine—Vinblastine—hematologic cancer	0.000312	0.115	CbGdCrCtD
Clonidine—ADRA2C—lung—hematologic cancer	0.0003	0.0157	CbGeAlD
Clonidine—SLC22A4—lymph node—hematologic cancer	0.000297	0.0155	CbGeAlD
Clonidine—CYP1A2—blood—hematologic cancer	0.000297	0.0155	CbGeAlD
Clonidine—CYP1A1—blood—hematologic cancer	0.000293	0.0153	CbGeAlD
Clonidine—SLC22A5—lung—hematologic cancer	0.000288	0.015	CbGeAlD
Clonidine—CYP3A5—blood—hematologic cancer	0.000287	0.015	CbGeAlD
Clonidine—ADRA2C—testis—hematologic cancer	0.000283	0.0148	CbGeAlD
Clonidine—ADRA2A—blood—hematologic cancer	0.000273	0.0143	CbGeAlD
Clonidine—SLC22A5—testis—hematologic cancer	0.000271	0.0142	CbGeAlD
Clonidine—SLC22A3—lymph node—hematologic cancer	0.000271	0.0141	CbGeAlD
Clonidine—CYP1A2—lung—hematologic cancer	0.000261	0.0136	CbGeAlD
Clonidine—CYP1A1—lung—hematologic cancer	0.000257	0.0134	CbGeAlD
Clonidine—CYP3A5—lung—hematologic cancer	0.000251	0.0131	CbGeAlD
Clonidine—NISCH—Vinblastine—Vincristine—hematologic cancer	0.000251	0.0926	CbGdCrCtD
Clonidine—ADRA2A—lung—hematologic cancer	0.00024	0.0125	CbGeAlD
Clonidine—SLC6A2—lymph node—hematologic cancer	0.000232	0.0121	CbGeAlD
Clonidine—ABCB1—hematopoietic system—hematologic cancer	0.00023	0.012	CbGeAlD
Clonidine—ADRA2A—testis—hematologic cancer	0.000226	0.0118	CbGeAlD
Clonidine—CYP3A4—blood—hematologic cancer	0.000215	0.0112	CbGeAlD
Clonidine—CYP2D6—blood—hematologic cancer	0.000212	0.0111	CbGeAlD
Clonidine—ADRA2C—lymph node—hematologic cancer	0.000205	0.0107	CbGeAlD
Clonidine—SLC22A5—lymph node—hematologic cancer	0.000197	0.0103	CbGeAlD
Clonidine—CYP1A1—lymph node—hematologic cancer	0.000176	0.00918	CbGeAlD
Clonidine—CYP2D6—testis—hematologic cancer	0.000175	0.00914	CbGeAlD
Clonidine—ABCB1—gonad—hematologic cancer	0.000175	0.00913	CbGeAlD
Clonidine—ADRA2A—lymph node—hematologic cancer	0.000164	0.00856	CbGeAlD
Clonidine—ABCB1—blood—hematologic cancer	0.000152	0.00795	CbGeAlD
Clonidine—ABCB1—bone marrow—hematologic cancer	0.000147	0.00769	CbGeAlD
Clonidine—ABCB1—lung—hematologic cancer	0.000134	0.00697	CbGeAlD
Clonidine—ABCB1—testis—hematologic cancer	0.000126	0.00658	CbGeAlD
Clonidine—ABCB1—lymph node—hematologic cancer	9.13e-05	0.00477	CbGeAlD
Clonidine—Diclofenac—ALB—hematologic cancer	8.54e-05	0.0937	CrCbGaD
Clonidine—Diclofenac—ABCB1—hematologic cancer	8.15e-05	0.0894	CrCbGaD
Clonidine—Nausea—Mitoxantrone—hematologic cancer	2.07e-05	0.000116	CcSEcCtD
Clonidine—Infection—Prednisone—hematologic cancer	2.06e-05	0.000116	CcSEcCtD
Clonidine—Mediastinal disorder—Epirubicin—hematologic cancer	2.06e-05	0.000116	CcSEcCtD
Clonidine—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Clonidine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Clonidine—Fatigue—Betamethasone—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Clonidine—Fatigue—Dexamethasone—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Clonidine—Pruritus—Etoposide—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Clonidine—Shock—Prednisone—hematologic cancer	2.04e-05	0.000115	CcSEcCtD
Clonidine—Arrhythmia—Epirubicin—hematologic cancer	2.04e-05	0.000115	CcSEcCtD
Clonidine—Pain—Betamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Clonidine—Pain—Dexamethasone—hematologic cancer	2.04e-05	0.000114	CcSEcCtD
Clonidine—Nervous system disorder—Prednisone—hematologic cancer	2.03e-05	0.000114	CcSEcCtD
Clonidine—Tachycardia—Prednisone—hematologic cancer	2.02e-05	0.000114	CcSEcCtD
Clonidine—Alopecia—Epirubicin—hematologic cancer	2.02e-05	0.000113	CcSEcCtD
Clonidine—Skin disorder—Prednisone—hematologic cancer	2.01e-05	0.000113	CcSEcCtD
Clonidine—Nausea—Gemcitabine—hematologic cancer	2.01e-05	0.000113	CcSEcCtD
Clonidine—Vomiting—Cisplatin—hematologic cancer	2.01e-05	0.000113	CcSEcCtD
Clonidine—Hyperhidrosis—Prednisone—hematologic cancer	2e-05	0.000113	CcSEcCtD
Clonidine—Vision blurred—Methotrexate—hematologic cancer	2e-05	0.000112	CcSEcCtD
Clonidine—Mental disorder—Epirubicin—hematologic cancer	2e-05	0.000112	CcSEcCtD
Clonidine—Rash—Cisplatin—hematologic cancer	1.99e-05	0.000112	CcSEcCtD
Clonidine—Dermatitis—Cisplatin—hematologic cancer	1.99e-05	0.000112	CcSEcCtD
Clonidine—Erythema—Epirubicin—hematologic cancer	1.99e-05	0.000112	CcSEcCtD
Clonidine—Diarrhoea—Etoposide—hematologic cancer	1.98e-05	0.000111	CcSEcCtD
Clonidine—Anorexia—Prednisone—hematologic cancer	1.98e-05	0.000111	CcSEcCtD
Clonidine—Eye disorder—Doxorubicin—hematologic cancer	1.97e-05	0.000111	CcSEcCtD
Clonidine—Ill-defined disorder—Methotrexate—hematologic cancer	1.97e-05	0.000111	CcSEcCtD
Clonidine—Tinnitus—Doxorubicin—hematologic cancer	1.97e-05	0.000111	CcSEcCtD
Clonidine—Feeling abnormal—Dexamethasone—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Clonidine—Feeling abnormal—Betamethasone—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Clonidine—Cardiac disorder—Doxorubicin—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Clonidine—Tension—Epirubicin—hematologic cancer	1.95e-05	0.00011	CcSEcCtD
Clonidine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.95e-05	0.000109	CcSEcCtD
Clonidine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.95e-05	0.000109	CcSEcCtD
Clonidine—Hypersensitivity—Triamcinolone—hematologic cancer	1.93e-05	0.000109	CcSEcCtD
Clonidine—Nervousness—Epirubicin—hematologic cancer	1.93e-05	0.000108	CcSEcCtD
Clonidine—Angiopathy—Doxorubicin—hematologic cancer	1.92e-05	0.000108	CcSEcCtD
Clonidine—Malaise—Methotrexate—hematologic cancer	1.91e-05	0.000108	CcSEcCtD
Clonidine—Dizziness—Etoposide—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Clonidine—Muscle spasms—Epirubicin—hematologic cancer	1.91e-05	0.000107	CcSEcCtD
Clonidine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.9e-05	0.000107	CcSEcCtD
Clonidine—Urticaria—Betamethasone—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Clonidine—Urticaria—Dexamethasone—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Clonidine—Dizziness—Prednisolone—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Clonidine—Arrhythmia—Doxorubicin—hematologic cancer	1.89e-05	0.000106	CcSEcCtD
Clonidine—Asthenia—Triamcinolone—hematologic cancer	1.88e-05	0.000106	CcSEcCtD
Clonidine—Abdominal pain—Betamethasone—hematologic cancer	1.88e-05	0.000106	CcSEcCtD
Clonidine—Abdominal pain—Dexamethasone—hematologic cancer	1.88e-05	0.000106	CcSEcCtD
Clonidine—Body temperature increased—Dexamethasone—hematologic cancer	1.88e-05	0.000106	CcSEcCtD
Clonidine—Body temperature increased—Betamethasone—hematologic cancer	1.88e-05	0.000106	CcSEcCtD
Clonidine—Nausea—Cisplatin—hematologic cancer	1.88e-05	0.000105	CcSEcCtD
Clonidine—Insomnia—Prednisone—hematologic cancer	1.87e-05	0.000105	CcSEcCtD
Clonidine—Vision blurred—Epirubicin—hematologic cancer	1.87e-05	0.000105	CcSEcCtD
Clonidine—Alopecia—Doxorubicin—hematologic cancer	1.87e-05	0.000105	CcSEcCtD
Clonidine—Paraesthesia—Prednisone—hematologic cancer	1.86e-05	0.000105	CcSEcCtD
Clonidine—Pruritus—Triamcinolone—hematologic cancer	1.86e-05	0.000104	CcSEcCtD
Clonidine—Cough—Methotrexate—hematologic cancer	1.85e-05	0.000104	CcSEcCtD
Clonidine—Mental disorder—Doxorubicin—hematologic cancer	1.85e-05	0.000104	CcSEcCtD
Clonidine—Ill-defined disorder—Epirubicin—hematologic cancer	1.84e-05	0.000104	CcSEcCtD
Clonidine—Vomiting—Etoposide—hematologic cancer	1.84e-05	0.000103	CcSEcCtD
Clonidine—Erythema—Doxorubicin—hematologic cancer	1.84e-05	0.000103	CcSEcCtD
Clonidine—Agitation—Epirubicin—hematologic cancer	1.83e-05	0.000103	CcSEcCtD
Clonidine—Rash—Etoposide—hematologic cancer	1.82e-05	0.000102	CcSEcCtD
Clonidine—Dermatitis—Etoposide—hematologic cancer	1.82e-05	0.000102	CcSEcCtD
Clonidine—Headache—Etoposide—hematologic cancer	1.81e-05	0.000102	CcSEcCtD
Clonidine—Arthralgia—Methotrexate—hematologic cancer	1.81e-05	0.000102	CcSEcCtD
Clonidine—Chest pain—Methotrexate—hematologic cancer	1.81e-05	0.000102	CcSEcCtD
Clonidine—Tension—Doxorubicin—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Clonidine—Decreased appetite—Prednisone—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Clonidine—Rash—Prednisolone—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Clonidine—Dermatitis—Prednisolone—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.79e-05	0.000101	CcSEcCtD
Clonidine—Malaise—Epirubicin—hematologic cancer	1.79e-05	0.000101	CcSEcCtD
Clonidine—Fatigue—Prednisone—hematologic cancer	1.79e-05	0.0001	CcSEcCtD
Clonidine—Headache—Prednisolone—hematologic cancer	1.79e-05	0.0001	CcSEcCtD
Clonidine—Discomfort—Methotrexate—hematologic cancer	1.79e-05	0.0001	CcSEcCtD
Clonidine—Nervousness—Doxorubicin—hematologic cancer	1.79e-05	0.0001	CcSEcCtD
Clonidine—Syncope—Epirubicin—hematologic cancer	1.78e-05	0.0001	CcSEcCtD
Clonidine—Constipation—Prednisone—hematologic cancer	1.77e-05	9.96e-05	CcSEcCtD
Clonidine—Muscle spasms—Doxorubicin—hematologic cancer	1.77e-05	9.93e-05	CcSEcCtD
Clonidine—Palpitations—Epirubicin—hematologic cancer	1.76e-05	9.87e-05	CcSEcCtD
Clonidine—Confusional state—Methotrexate—hematologic cancer	1.75e-05	9.82e-05	CcSEcCtD
Clonidine—Loss of consciousness—Epirubicin—hematologic cancer	1.75e-05	9.81e-05	CcSEcCtD
Clonidine—Dizziness—Triamcinolone—hematologic cancer	1.73e-05	9.75e-05	CcSEcCtD
Clonidine—Cough—Epirubicin—hematologic cancer	1.73e-05	9.74e-05	CcSEcCtD
Clonidine—Vision blurred—Doxorubicin—hematologic cancer	1.73e-05	9.74e-05	CcSEcCtD
Clonidine—Infection—Methotrexate—hematologic cancer	1.72e-05	9.67e-05	CcSEcCtD
Clonidine—Nausea—Etoposide—hematologic cancer	1.72e-05	9.65e-05	CcSEcCtD
Clonidine—Feeling abnormal—Prednisone—hematologic cancer	1.71e-05	9.6e-05	CcSEcCtD
Clonidine—Asthenia—Dexamethasone—hematologic cancer	1.71e-05	9.6e-05	CcSEcCtD
Clonidine—Asthenia—Betamethasone—hematologic cancer	1.71e-05	9.6e-05	CcSEcCtD
Clonidine—Ill-defined disorder—Doxorubicin—hematologic cancer	1.71e-05	9.58e-05	CcSEcCtD
Clonidine—Nervous system disorder—Methotrexate—hematologic cancer	1.7e-05	9.55e-05	CcSEcCtD
Clonidine—Thrombocytopenia—Methotrexate—hematologic cancer	1.7e-05	9.53e-05	CcSEcCtD
Clonidine—Gastrointestinal pain—Prednisone—hematologic cancer	1.7e-05	9.53e-05	CcSEcCtD
Clonidine—Nausea—Prednisolone—hematologic cancer	1.69e-05	9.52e-05	CcSEcCtD
Clonidine—Arthralgia—Epirubicin—hematologic cancer	1.69e-05	9.5e-05	CcSEcCtD
Clonidine—Chest pain—Epirubicin—hematologic cancer	1.69e-05	9.5e-05	CcSEcCtD
Clonidine—Agitation—Doxorubicin—hematologic cancer	1.69e-05	9.49e-05	CcSEcCtD
Clonidine—Anxiety—Epirubicin—hematologic cancer	1.69e-05	9.47e-05	CcSEcCtD
Clonidine—Pruritus—Dexamethasone—hematologic cancer	1.68e-05	9.46e-05	CcSEcCtD
Clonidine—Pruritus—Betamethasone—hematologic cancer	1.68e-05	9.46e-05	CcSEcCtD
Clonidine—Skin disorder—Methotrexate—hematologic cancer	1.68e-05	9.46e-05	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.68e-05	9.44e-05	CcSEcCtD
Clonidine—Hyperhidrosis—Methotrexate—hematologic cancer	1.67e-05	9.41e-05	CcSEcCtD
Clonidine—Discomfort—Epirubicin—hematologic cancer	1.67e-05	9.39e-05	CcSEcCtD
Clonidine—Vomiting—Triamcinolone—hematologic cancer	1.67e-05	9.37e-05	CcSEcCtD
Clonidine—Malaise—Doxorubicin—hematologic cancer	1.66e-05	9.32e-05	CcSEcCtD
Clonidine—Rash—Triamcinolone—hematologic cancer	1.65e-05	9.3e-05	CcSEcCtD
Clonidine—Dry mouth—Epirubicin—hematologic cancer	1.65e-05	9.3e-05	CcSEcCtD
Clonidine—Dermatitis—Triamcinolone—hematologic cancer	1.65e-05	9.29e-05	CcSEcCtD
Clonidine—Anorexia—Methotrexate—hematologic cancer	1.65e-05	9.28e-05	CcSEcCtD
Clonidine—Syncope—Doxorubicin—hematologic cancer	1.65e-05	9.26e-05	CcSEcCtD
Clonidine—Urticaria—Prednisone—hematologic cancer	1.65e-05	9.25e-05	CcSEcCtD
Clonidine—Headache—Triamcinolone—hematologic cancer	1.64e-05	9.24e-05	CcSEcCtD
Clonidine—Body temperature increased—Prednisone—hematologic cancer	1.64e-05	9.21e-05	CcSEcCtD
Clonidine—Abdominal pain—Prednisone—hematologic cancer	1.64e-05	9.21e-05	CcSEcCtD
Clonidine—Confusional state—Epirubicin—hematologic cancer	1.63e-05	9.19e-05	CcSEcCtD
Clonidine—Diarrhoea—Betamethasone—hematologic cancer	1.63e-05	9.15e-05	CcSEcCtD
Clonidine—Diarrhoea—Dexamethasone—hematologic cancer	1.63e-05	9.15e-05	CcSEcCtD
Clonidine—Palpitations—Doxorubicin—hematologic cancer	1.62e-05	9.13e-05	CcSEcCtD
Clonidine—Oedema—Epirubicin—hematologic cancer	1.62e-05	9.11e-05	CcSEcCtD
Clonidine—Hypotension—Methotrexate—hematologic cancer	1.62e-05	9.1e-05	CcSEcCtD
Clonidine—Loss of consciousness—Doxorubicin—hematologic cancer	1.62e-05	9.08e-05	CcSEcCtD
Clonidine—Infection—Epirubicin—hematologic cancer	1.61e-05	9.05e-05	CcSEcCtD
Clonidine—Cough—Doxorubicin—hematologic cancer	1.6e-05	9.01e-05	CcSEcCtD
Clonidine—Shock—Epirubicin—hematologic cancer	1.6e-05	8.96e-05	CcSEcCtD
Clonidine—Nervous system disorder—Epirubicin—hematologic cancer	1.59e-05	8.94e-05	CcSEcCtD
Clonidine—Thrombocytopenia—Epirubicin—hematologic cancer	1.59e-05	8.92e-05	CcSEcCtD
Clonidine—Tachycardia—Epirubicin—hematologic cancer	1.58e-05	8.89e-05	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.58e-05	8.87e-05	CcSEcCtD
Clonidine—Skin disorder—Epirubicin—hematologic cancer	1.57e-05	8.85e-05	CcSEcCtD
Clonidine—Dizziness—Betamethasone—hematologic cancer	1.57e-05	8.85e-05	CcSEcCtD
Clonidine—Dizziness—Dexamethasone—hematologic cancer	1.57e-05	8.85e-05	CcSEcCtD
Clonidine—Hyperhidrosis—Epirubicin—hematologic cancer	1.57e-05	8.81e-05	CcSEcCtD
Clonidine—Insomnia—Methotrexate—hematologic cancer	1.57e-05	8.81e-05	CcSEcCtD
Clonidine—Chest pain—Doxorubicin—hematologic cancer	1.56e-05	8.79e-05	CcSEcCtD
Clonidine—Arthralgia—Doxorubicin—hematologic cancer	1.56e-05	8.79e-05	CcSEcCtD
Clonidine—Anxiety—Doxorubicin—hematologic cancer	1.56e-05	8.76e-05	CcSEcCtD
Clonidine—Nausea—Triamcinolone—hematologic cancer	1.56e-05	8.76e-05	CcSEcCtD
Clonidine—Paraesthesia—Methotrexate—hematologic cancer	1.56e-05	8.74e-05	CcSEcCtD
Clonidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.55e-05	8.73e-05	CcSEcCtD
Clonidine—Discomfort—Doxorubicin—hematologic cancer	1.55e-05	8.69e-05	CcSEcCtD
Clonidine—Anorexia—Epirubicin—hematologic cancer	1.55e-05	8.68e-05	CcSEcCtD
Clonidine—Dyspnoea—Methotrexate—hematologic cancer	1.54e-05	8.68e-05	CcSEcCtD
Clonidine—Somnolence—Methotrexate—hematologic cancer	1.54e-05	8.66e-05	CcSEcCtD
Clonidine—Dry mouth—Doxorubicin—hematologic cancer	1.53e-05	8.6e-05	CcSEcCtD
Clonidine—Hypersensitivity—Prednisone—hematologic cancer	1.53e-05	8.58e-05	CcSEcCtD
Clonidine—Hypotension—Epirubicin—hematologic cancer	1.51e-05	8.51e-05	CcSEcCtD
Clonidine—Vomiting—Betamethasone—hematologic cancer	1.51e-05	8.51e-05	CcSEcCtD
Clonidine—Vomiting—Dexamethasone—hematologic cancer	1.51e-05	8.51e-05	CcSEcCtD
Clonidine—Confusional state—Doxorubicin—hematologic cancer	1.51e-05	8.5e-05	CcSEcCtD
Clonidine—Decreased appetite—Methotrexate—hematologic cancer	1.51e-05	8.46e-05	CcSEcCtD
Clonidine—Rash—Dexamethasone—hematologic cancer	1.5e-05	8.43e-05	CcSEcCtD
Clonidine—Rash—Betamethasone—hematologic cancer	1.5e-05	8.43e-05	CcSEcCtD
Clonidine—Oedema—Doxorubicin—hematologic cancer	1.5e-05	8.43e-05	CcSEcCtD
Clonidine—Dermatitis—Dexamethasone—hematologic cancer	1.5e-05	8.43e-05	CcSEcCtD
Clonidine—Dermatitis—Betamethasone—hematologic cancer	1.5e-05	8.43e-05	CcSEcCtD
Clonidine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.5e-05	8.41e-05	CcSEcCtD
Clonidine—Fatigue—Methotrexate—hematologic cancer	1.49e-05	8.39e-05	CcSEcCtD
Clonidine—Headache—Dexamethasone—hematologic cancer	1.49e-05	8.38e-05	CcSEcCtD
Clonidine—Headache—Betamethasone—hematologic cancer	1.49e-05	8.38e-05	CcSEcCtD
Clonidine—Infection—Doxorubicin—hematologic cancer	1.49e-05	8.38e-05	CcSEcCtD
Clonidine—Asthenia—Prednisone—hematologic cancer	1.49e-05	8.36e-05	CcSEcCtD
Clonidine—Pain—Methotrexate—hematologic cancer	1.48e-05	8.33e-05	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.48e-05	8.3e-05	CcSEcCtD
Clonidine—Shock—Doxorubicin—hematologic cancer	1.48e-05	8.29e-05	CcSEcCtD
Clonidine—Nervous system disorder—Doxorubicin—hematologic cancer	1.47e-05	8.27e-05	CcSEcCtD
Clonidine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.47e-05	8.25e-05	CcSEcCtD
Clonidine—Pruritus—Prednisone—hematologic cancer	1.47e-05	8.24e-05	CcSEcCtD
Clonidine—Insomnia—Epirubicin—hematologic cancer	1.47e-05	8.24e-05	CcSEcCtD
Clonidine—Tachycardia—Doxorubicin—hematologic cancer	1.46e-05	8.23e-05	CcSEcCtD
Clonidine—Skin disorder—Doxorubicin—hematologic cancer	1.46e-05	8.19e-05	CcSEcCtD
Clonidine—Paraesthesia—Epirubicin—hematologic cancer	1.46e-05	8.18e-05	CcSEcCtD
Clonidine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.45e-05	8.15e-05	CcSEcCtD
Clonidine—Dyspnoea—Epirubicin—hematologic cancer	1.45e-05	8.12e-05	CcSEcCtD
Clonidine—Somnolence—Epirubicin—hematologic cancer	1.44e-05	8.1e-05	CcSEcCtD
Clonidine—Anorexia—Doxorubicin—hematologic cancer	1.43e-05	8.04e-05	CcSEcCtD
Clonidine—Feeling abnormal—Methotrexate—hematologic cancer	1.43e-05	8.02e-05	CcSEcCtD
Clonidine—Diarrhoea—Prednisone—hematologic cancer	1.42e-05	7.97e-05	CcSEcCtD
Clonidine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.42e-05	7.96e-05	CcSEcCtD
Clonidine—Nausea—Betamethasone—hematologic cancer	1.41e-05	7.95e-05	CcSEcCtD
Clonidine—Nausea—Dexamethasone—hematologic cancer	1.41e-05	7.95e-05	CcSEcCtD
Clonidine—Decreased appetite—Epirubicin—hematologic cancer	1.41e-05	7.92e-05	CcSEcCtD
Clonidine—Hypotension—Doxorubicin—hematologic cancer	1.4e-05	7.88e-05	CcSEcCtD
Clonidine—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.4e-05	7.87e-05	CcSEcCtD
Clonidine—Fatigue—Epirubicin—hematologic cancer	1.4e-05	7.86e-05	CcSEcCtD
Clonidine—Pain—Epirubicin—hematologic cancer	1.39e-05	7.79e-05	CcSEcCtD
Clonidine—Constipation—Epirubicin—hematologic cancer	1.39e-05	7.79e-05	CcSEcCtD
Clonidine—Urticaria—Methotrexate—hematologic cancer	1.38e-05	7.73e-05	CcSEcCtD
Clonidine—Dizziness—Prednisone—hematologic cancer	1.37e-05	7.7e-05	CcSEcCtD
Clonidine—Abdominal pain—Methotrexate—hematologic cancer	1.37e-05	7.7e-05	CcSEcCtD
Clonidine—Body temperature increased—Methotrexate—hematologic cancer	1.37e-05	7.7e-05	CcSEcCtD
Clonidine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.37e-05	7.68e-05	CcSEcCtD
Clonidine—Insomnia—Doxorubicin—hematologic cancer	1.36e-05	7.63e-05	CcSEcCtD
Clonidine—Paraesthesia—Doxorubicin—hematologic cancer	1.35e-05	7.57e-05	CcSEcCtD
Clonidine—Dyspnoea—Doxorubicin—hematologic cancer	1.34e-05	7.52e-05	CcSEcCtD
Clonidine—Feeling abnormal—Epirubicin—hematologic cancer	1.34e-05	7.51e-05	CcSEcCtD
Clonidine—Somnolence—Doxorubicin—hematologic cancer	1.33e-05	7.49e-05	CcSEcCtD
Clonidine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.33e-05	7.45e-05	CcSEcCtD
Clonidine—Vomiting—Prednisone—hematologic cancer	1.32e-05	7.41e-05	CcSEcCtD
Clonidine—Rash—Prednisone—hematologic cancer	1.31e-05	7.35e-05	CcSEcCtD
Clonidine—Dermatitis—Prednisone—hematologic cancer	1.31e-05	7.34e-05	CcSEcCtD
Clonidine—Decreased appetite—Doxorubicin—hematologic cancer	1.3e-05	7.33e-05	CcSEcCtD
Clonidine—Headache—Prednisone—hematologic cancer	1.3e-05	7.3e-05	CcSEcCtD
Clonidine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.3e-05	7.28e-05	CcSEcCtD
Clonidine—Fatigue—Doxorubicin—hematologic cancer	1.29e-05	7.27e-05	CcSEcCtD
Clonidine—Urticaria—Epirubicin—hematologic cancer	1.29e-05	7.24e-05	CcSEcCtD
Clonidine—Pain—Doxorubicin—hematologic cancer	1.28e-05	7.21e-05	CcSEcCtD
Clonidine—Constipation—Doxorubicin—hematologic cancer	1.28e-05	7.21e-05	CcSEcCtD
Clonidine—Abdominal pain—Epirubicin—hematologic cancer	1.28e-05	7.2e-05	CcSEcCtD
Clonidine—Body temperature increased—Epirubicin—hematologic cancer	1.28e-05	7.2e-05	CcSEcCtD
Clonidine—Hypersensitivity—Methotrexate—hematologic cancer	1.28e-05	7.17e-05	CcSEcCtD
Clonidine—Asthenia—Methotrexate—hematologic cancer	1.24e-05	6.99e-05	CcSEcCtD
Clonidine—Feeling abnormal—Doxorubicin—hematologic cancer	1.24e-05	6.95e-05	CcSEcCtD
Clonidine—Nausea—Prednisone—hematologic cancer	1.23e-05	6.92e-05	CcSEcCtD
Clonidine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.23e-05	6.89e-05	CcSEcCtD
Clonidine—Pruritus—Methotrexate—hematologic cancer	1.23e-05	6.89e-05	CcSEcCtD
Clonidine—Hypersensitivity—Epirubicin—hematologic cancer	1.19e-05	6.71e-05	CcSEcCtD
Clonidine—Urticaria—Doxorubicin—hematologic cancer	1.19e-05	6.7e-05	CcSEcCtD
Clonidine—Abdominal pain—Doxorubicin—hematologic cancer	1.19e-05	6.66e-05	CcSEcCtD
Clonidine—Body temperature increased—Doxorubicin—hematologic cancer	1.19e-05	6.66e-05	CcSEcCtD
Clonidine—Diarrhoea—Methotrexate—hematologic cancer	1.19e-05	6.66e-05	CcSEcCtD
Clonidine—Asthenia—Epirubicin—hematologic cancer	1.16e-05	6.54e-05	CcSEcCtD
Clonidine—Pruritus—Epirubicin—hematologic cancer	1.15e-05	6.45e-05	CcSEcCtD
Clonidine—Dizziness—Methotrexate—hematologic cancer	1.15e-05	6.44e-05	CcSEcCtD
Clonidine—Diarrhoea—Epirubicin—hematologic cancer	1.11e-05	6.23e-05	CcSEcCtD
Clonidine—Hypersensitivity—Doxorubicin—hematologic cancer	1.11e-05	6.21e-05	CcSEcCtD
Clonidine—Vomiting—Methotrexate—hematologic cancer	1.1e-05	6.19e-05	CcSEcCtD
Clonidine—Rash—Methotrexate—hematologic cancer	1.09e-05	6.14e-05	CcSEcCtD
Clonidine—Dermatitis—Methotrexate—hematologic cancer	1.09e-05	6.13e-05	CcSEcCtD
Clonidine—Headache—Methotrexate—hematologic cancer	1.09e-05	6.1e-05	CcSEcCtD
Clonidine—Asthenia—Doxorubicin—hematologic cancer	1.08e-05	6.05e-05	CcSEcCtD
Clonidine—Dizziness—Epirubicin—hematologic cancer	1.07e-05	6.03e-05	CcSEcCtD
Clonidine—Pruritus—Doxorubicin—hematologic cancer	1.06e-05	5.96e-05	CcSEcCtD
Clonidine—Vomiting—Epirubicin—hematologic cancer	1.03e-05	5.79e-05	CcSEcCtD
Clonidine—Nausea—Methotrexate—hematologic cancer	1.03e-05	5.78e-05	CcSEcCtD
Clonidine—Diarrhoea—Doxorubicin—hematologic cancer	1.03e-05	5.77e-05	CcSEcCtD
Clonidine—Rash—Epirubicin—hematologic cancer	1.02e-05	5.74e-05	CcSEcCtD
Clonidine—Dermatitis—Epirubicin—hematologic cancer	1.02e-05	5.74e-05	CcSEcCtD
Clonidine—Headache—Epirubicin—hematologic cancer	1.02e-05	5.71e-05	CcSEcCtD
Clonidine—Dizziness—Doxorubicin—hematologic cancer	9.92e-06	5.57e-05	CcSEcCtD
Clonidine—Nausea—Epirubicin—hematologic cancer	9.63e-06	5.41e-05	CcSEcCtD
Clonidine—Vomiting—Doxorubicin—hematologic cancer	9.54e-06	5.36e-05	CcSEcCtD
Clonidine—Rash—Doxorubicin—hematologic cancer	9.46e-06	5.32e-05	CcSEcCtD
Clonidine—Dermatitis—Doxorubicin—hematologic cancer	9.45e-06	5.31e-05	CcSEcCtD
Clonidine—Headache—Doxorubicin—hematologic cancer	9.4e-06	5.28e-05	CcSEcCtD
Clonidine—Nausea—Doxorubicin—hematologic cancer	8.91e-06	5.01e-05	CcSEcCtD
Clonidine—ADRA2B—GPCR downstream signaling—AKT1—hematologic cancer	1.73e-06	2.5e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.73e-06	2.5e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.73e-06	2.5e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PTEN—hematologic cancer	1.73e-06	2.49e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCL2—hematologic cancer	1.72e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—EP300—hematologic cancer	1.72e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CASP3—hematologic cancer	1.72e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6R—hematologic cancer	1.71e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CB—hematologic cancer	1.71e-06	2.48e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MTOR—hematologic cancer	1.71e-06	2.48e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.71e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL2—hematologic cancer	1.71e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CREBBP—hematologic cancer	1.71e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—KRAS—hematologic cancer	1.71e-06	2.47e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—IL6—hematologic cancer	1.7e-06	2.46e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—EP300—hematologic cancer	1.7e-06	2.46e-05	CbGpPWpGaD
Clonidine—SLC22A3—Metabolism—AKT1—hematologic cancer	1.7e-06	2.46e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CB—hematologic cancer	1.69e-06	2.44e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ABCB1—hematologic cancer	1.69e-06	2.44e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CD—hematologic cancer	1.68e-06	2.43e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.68e-06	2.43e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—FGF2—hematologic cancer	1.67e-06	2.42e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CCND1—hematologic cancer	1.67e-06	2.41e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—JUN—hematologic cancer	1.67e-06	2.41e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—HRAS—hematologic cancer	1.66e-06	2.4e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—ALB—hematologic cancer	1.66e-06	2.4e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—SRC—hematologic cancer	1.66e-06	2.39e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NQO1—hematologic cancer	1.65e-06	2.39e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CD44—hematologic cancer	1.65e-06	2.39e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3R1—hematologic cancer	1.65e-06	2.38e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—EP300—hematologic cancer	1.65e-06	2.38e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.64e-06	2.37e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.64e-06	2.37e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—HRAS—hematologic cancer	1.64e-06	2.36e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1B—hematologic cancer	1.63e-06	2.36e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAP2K1—hematologic cancer	1.63e-06	2.36e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CD—hematologic cancer	1.62e-06	2.34e-05	CbGpPWpGaD
Clonidine—ADRA2C—GPCR downstream signaling—AKT1—hematologic cancer	1.62e-06	2.34e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—CDKN1A—hematologic cancer	1.62e-06	2.33e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—VEGFA—hematologic cancer	1.61e-06	2.33e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PTEN—hematologic cancer	1.61e-06	2.33e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1B—hematologic cancer	1.61e-06	2.32e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—PIK3CA—hematologic cancer	1.61e-06	2.32e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—JAK2—hematologic cancer	1.6e-06	2.32e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CASP3—hematologic cancer	1.6e-06	2.31e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL2—hematologic cancer	1.6e-06	2.31e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—STAT3—hematologic cancer	1.6e-06	2.31e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—NRAS—hematologic cancer	1.59e-06	2.3e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—IL6—hematologic cancer	1.59e-06	2.3e-05	CbGpPWpGaD
Clonidine—ADRA1B—GPCR downstream signaling—AKT1—hematologic cancer	1.59e-06	2.3e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—KRAS—hematologic cancer	1.59e-06	2.3e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3R1—hematologic cancer	1.59e-06	2.29e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CASP3—hematologic cancer	1.58e-06	2.28e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK8—hematologic cancer	1.58e-06	2.28e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL2—hematologic cancer	1.57e-06	2.27e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling by GPCR—AKT1—hematologic cancer	1.57e-06	2.27e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—PIK3CA—hematologic cancer	1.57e-06	2.27e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—IL6—hematologic cancer	1.57e-06	2.26e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MDM2—hematologic cancer	1.57e-06	2.26e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.56e-06	2.26e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CCND1—hematologic cancer	1.56e-06	2.25e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—JUN—hematologic cancer	1.56e-06	2.25e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.55e-06	2.24e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—FGF2—hematologic cancer	1.55e-06	2.24e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.55e-06	2.24e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—EP300—hematologic cancer	1.54e-06	2.22e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CCND1—hematologic cancer	1.53e-06	2.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3R1—hematologic cancer	1.53e-06	2.21e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—JUN—hematologic cancer	1.53e-06	2.21e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.53e-06	2.21e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MAPK3—hematologic cancer	1.53e-06	2.2e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MTOR—hematologic cancer	1.52e-06	2.2e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CB—hematologic cancer	1.52e-06	2.2e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—CDKN1A—hematologic cancer	1.51e-06	2.18e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PTEN—hematologic cancer	1.51e-06	2.17e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—SRC—hematologic cancer	1.49e-06	2.16e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—JAK2—hematologic cancer	1.49e-06	2.15e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—CDKN1A—hematologic cancer	1.48e-06	2.14e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—MYC—hematologic cancer	1.48e-06	2.14e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PTEN—hematologic cancer	1.48e-06	2.14e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TGFB1—hematologic cancer	1.48e-06	2.14e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK8—hematologic cancer	1.47e-06	2.13e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling by GPCR—AKT1—hematologic cancer	1.47e-06	2.12e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CB—hematologic cancer	1.46e-06	2.12e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PTEN—hematologic cancer	1.46e-06	2.11e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—PIK3CA—hematologic cancer	1.46e-06	2.11e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—VEGFA—hematologic cancer	1.46e-06	2.1e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MDM2—hematologic cancer	1.45e-06	2.1e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—HRAS—hematologic cancer	1.45e-06	2.1e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.45e-06	2.1e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK8—hematologic cancer	1.45e-06	2.09e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling by GPCR—AKT1—hematologic cancer	1.45e-06	2.09e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—STAT3—hematologic cancer	1.44e-06	2.08e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.44e-06	2.08e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—NRAS—hematologic cancer	1.44e-06	2.08e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—EP300—hematologic cancer	1.44e-06	2.07e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1B—hematologic cancer	1.43e-06	2.06e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.42e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CB—hematologic cancer	1.41e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MTOR—hematologic cancer	1.41e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—GPCR downstream signaling—AKT1—hematologic cancer	1.41e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—EP300—hematologic cancer	1.41e-06	2.04e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CASP3—hematologic cancer	1.4e-06	2.02e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL2—hematologic cancer	1.4e-06	2.02e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—SRC—hematologic cancer	1.4e-06	2.02e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—EP300—hematologic cancer	1.39e-06	2.01e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—IL6—hematologic cancer	1.39e-06	2.01e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.38e-06	1.99e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MAPK3—hematologic cancer	1.38e-06	1.99e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—SRC—hematologic cancer	1.37e-06	1.98e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—KRAS—hematologic cancer	1.37e-06	1.98e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CCND1—hematologic cancer	1.36e-06	1.97e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—JUN—hematologic cancer	1.36e-06	1.96e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—VEGFA—hematologic cancer	1.36e-06	1.96e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—HRAS—hematologic cancer	1.35e-06	1.95e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—STAT3—hematologic cancer	1.35e-06	1.94e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—NRAS—hematologic cancer	1.34e-06	1.94e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.34e-06	1.94e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PTEN—hematologic cancer	1.34e-06	1.94e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—MYC—hematologic cancer	1.34e-06	1.93e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—VEGFA—hematologic cancer	1.34e-06	1.93e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TGFB1—hematologic cancer	1.34e-06	1.93e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.33e-06	1.93e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1B—hematologic cancer	1.33e-06	1.92e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—ALB—hematologic cancer	1.33e-06	1.91e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—STAT3—hematologic cancer	1.32e-06	1.91e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—NRAS—hematologic cancer	1.32e-06	1.91e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—CDKN1A—hematologic cancer	1.32e-06	1.9e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PTEN—hematologic cancer	1.32e-06	1.9e-05	CbGpPWpGaD
Clonidine—ADRA2A—GPCR downstream signaling—AKT1—hematologic cancer	1.31e-06	1.9e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.31e-06	1.88e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CASP3—hematologic cancer	1.3e-06	1.88e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL2—hematologic cancer	1.3e-06	1.88e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—IL6—hematologic cancer	1.29e-06	1.87e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK8—hematologic cancer	1.29e-06	1.86e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MAPK3—hematologic cancer	1.29e-06	1.86e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling by GPCR—AKT1—hematologic cancer	1.28e-06	1.85e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.28e-06	1.85e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—EP300—hematologic cancer	1.28e-06	1.85e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—PIK3CA—hematologic cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CCND1—hematologic cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PTEN—hematologic cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MAPK3—hematologic cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.27e-06	1.83e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—JUN—hematologic cancer	1.26e-06	1.83e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—PIK3CA—hematologic cancer	1.26e-06	1.82e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—EP300—hematologic cancer	1.25e-06	1.81e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—MYC—hematologic cancer	1.25e-06	1.81e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—ALB—hematologic cancer	1.25e-06	1.8e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TGFB1—hematologic cancer	1.25e-06	1.8e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—KRAS—hematologic cancer	1.24e-06	1.79e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—MYC—hematologic cancer	1.23e-06	1.78e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TGFB1—hematologic cancer	1.23e-06	1.77e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—CDKN1A—hematologic cancer	1.23e-06	1.77e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PTEN—hematologic cancer	1.22e-06	1.77e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—SRC—hematologic cancer	1.22e-06	1.76e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.22e-06	1.76e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—TP53—hematologic cancer	1.22e-06	1.76e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—PIK3CA—hematologic cancer	1.22e-06	1.76e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—EP300—hematologic cancer	1.21e-06	1.74e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK8—hematologic cancer	1.2e-06	1.73e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.19e-06	1.73e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling by GPCR—AKT1—hematologic cancer	1.19e-06	1.72e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—VEGFA—hematologic cancer	1.19e-06	1.72e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—STAT3—hematologic cancer	1.18e-06	1.7e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—NRAS—hematologic cancer	1.17e-06	1.7e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.17e-06	1.69e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—EP300—hematologic cancer	1.17e-06	1.68e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—HRAS—hematologic cancer	1.17e-06	1.68e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—KRAS—hematologic cancer	1.16e-06	1.67e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—KRAS—hematologic cancer	1.14e-06	1.64e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—PIK3CA—hematologic cancer	1.14e-06	1.64e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—SRC—hematologic cancer	1.13e-06	1.64e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.13e-06	1.63e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MAPK3—hematologic cancer	1.12e-06	1.62e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.12e-06	1.62e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—IL6—hematologic cancer	1.12e-06	1.61e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—VEGFA—hematologic cancer	1.1e-06	1.59e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.1e-06	1.59e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—TP53—hematologic cancer	1.1e-06	1.59e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—MYC—hematologic cancer	1.09e-06	1.58e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—STAT3—hematologic cancer	1.09e-06	1.58e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TGFB1—hematologic cancer	1.09e-06	1.58e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—NRAS—hematologic cancer	1.09e-06	1.58e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.07e-06	1.55e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—PIK3CA—hematologic cancer	1.06e-06	1.53e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—ALB—hematologic cancer	1.06e-06	1.53e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—HRAS—hematologic cancer	1.05e-06	1.52e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—PIK3CA—hematologic cancer	1.05e-06	1.51e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MAPK3—hematologic cancer	1.04e-06	1.51e-05	CbGpPWpGaD
Clonidine—ADRA2C—Metabolism—AKT1—hematologic cancer	1.04e-06	1.5e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—PIK3CA—hematologic cancer	1.03e-06	1.49e-05	CbGpPWpGaD
Clonidine—ADRA1D—Signaling Pathways—AKT1—hematologic cancer	1.03e-06	1.49e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—TP53—hematologic cancer	1.03e-06	1.48e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—MYC—hematologic cancer	1.02e-06	1.47e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TGFB1—hematologic cancer	1.01e-06	1.46e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.01e-06	1.46e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PTEN—hematologic cancer	1.01e-06	1.46e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—TP53—hematologic cancer	1.01e-06	1.46e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—KRAS—hematologic cancer	1.01e-06	1.46e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—IL6—hematologic cancer	1.01e-06	1.45e-05	CbGpPWpGaD
Clonidine—SLC22A1—Metabolism—AKT1—hematologic cancer	9.94e-07	1.44e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—HRAS—hematologic cancer	9.82e-07	1.42e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—HRAS—hematologic cancer	9.67e-07	1.4e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—EP300—hematologic cancer	9.64e-07	1.39e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PTEN—hematologic cancer	9.53e-07	1.38e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	9.45e-07	1.37e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	9.41e-07	1.36e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—IL6—hematologic cancer	9.4e-07	1.36e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—KRAS—hematologic cancer	9.39e-07	1.36e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	9.34e-07	1.35e-05	CbGpPWpGaD
Clonidine—ADRA2B—Signaling Pathways—AKT1—hematologic cancer	9.29e-07	1.34e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—PIK3CA—hematologic cancer	9.28e-07	1.34e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—IL6—hematologic cancer	9.25e-07	1.34e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—EP300—hematologic cancer	9.09e-07	1.31e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—TP53—hematologic cancer	8.98e-07	1.3e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—PIK3CA—hematologic cancer	8.93e-07	1.29e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—CREBBP—hematologic cancer	8.72e-07	1.26e-05	CbGpPWpGaD
Clonidine—ADRA2C—Signaling Pathways—AKT1—hematologic cancer	8.67e-07	1.25e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—PIK3CA—hematologic cancer	8.63e-07	1.25e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—HRAS—hematologic cancer	8.59e-07	1.24e-05	CbGpPWpGaD
Clonidine—ADRA1B—Signaling Pathways—AKT1—hematologic cancer	8.54e-07	1.23e-05	CbGpPWpGaD
Clonidine—ADRA2A—Metabolism—AKT1—hematologic cancer	8.43e-07	1.22e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—TP53—hematologic cancer	8.34e-07	1.21e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	8.27e-07	1.19e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—IL6—hematologic cancer	8.22e-07	1.19e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—ALB—hematologic cancer	8.16e-07	1.18e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PTEN—hematologic cancer	8.07e-07	1.17e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—HRAS—hematologic cancer	7.98e-07	1.15e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	7.81e-07	1.13e-05	CbGpPWpGaD
Clonidine—CYP3A5—Metabolism—AKT1—hematologic cancer	7.72e-07	1.12e-05	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—EP300—hematologic cancer	7.7e-07	1.11e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—IL6—hematologic cancer	7.64e-07	1.1e-05	CbGpPWpGaD
Clonidine—ADRA1A—Signaling Pathways—AKT1—hematologic cancer	7.58e-07	1.1e-05	CbGpPWpGaD
Clonidine—CYP1A1—Metabolism—AKT1—hematologic cancer	7.3e-07	1.05e-05	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.21e-07	1.04e-05	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.13e-07	1.03e-05	CbGpPWpGaD
Clonidine—ADRA2A—Signaling Pathways—AKT1—hematologic cancer	7.05e-07	1.02e-05	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	6.72e-07	9.71e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PTEN—hematologic cancer	6.23e-07	9e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—EP300—hematologic cancer	5.94e-07	8.58e-06	CbGpPWpGaD
Clonidine—ABCB1—Metabolism—AKT1—hematologic cancer	5.83e-07	8.42e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	5.69e-07	8.22e-06	CbGpPWpGaD
Clonidine—CYP2D6—Metabolism—AKT1—hematologic cancer	5.49e-07	7.93e-06	CbGpPWpGaD
Clonidine—CYP1A2—Metabolism—AKT1—hematologic cancer	4.65e-07	6.72e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.39e-07	6.35e-06	CbGpPWpGaD
Clonidine—CYP3A4—Metabolism—AKT1—hematologic cancer	3.59e-07	5.18e-06	CbGpPWpGaD
